BREAKING: Virologist Nathan Wolfe, a prominent figure at Stanford University, will end his visiting appointment in the bioengineering department effective this Monday. This decision follows revelations of his association with the late convicted sex offender Jeffrey Epstein, as confirmed by a university spokesperson.
The Stanford Daily reported on Wolfe’s troubling connections to Epstein, including an invitation for Epstein to meet “a couple of hottie interns.” Wolfe had previously sought Epstein’s financial support for his research aimed at developing a “female viagra,” linked to what he referred to as “[their] horny virus hypothesis.” This controversial relationship has raised significant ethical concerns, prompting Wolfe’s decision not to renew his appointment.
In light of the investigation, Wolfe issued a statement asserting his innocence: “I never witnessed or participated in any misconduct or inappropriate behavior,” he told the Stanford Daily. Despite this assertion, the fallout from the Epstein connections has led to Wolfe’s departure from Stanford’s esteemed bioengineering program.
Wolfe, who previously held the title of Lorey I. Lokey Visiting Professor of Human Biology, had his LinkedIn profile updated to reflect his role as a “Visiting Scholar” at Stanford from 2023 until February 2026. However, the university confirmed that his tenure in the bioengineering department was limited to just one year and will not be extended.
Wolfe has not responded to requests for comments regarding his future affiliation with Stanford. As the university navigates the implications of this scandal, questions remain about the broader impact on academic ethics and research funding.
The situation is developing, and more updates are expected as Stanford addresses the fallout from Wolfe’s association with Epstein. This incident underscores the urgent need for transparency and accountability in academic institutions, particularly regarding the sources of research funding and the integrity of professional relationships.
Stay tuned for further developments on this pressing story.
